您当前的位置:首页 >  教学资源 >  教学考试试卷 > 内容

慢性肺源性心脏病抗凝物质抗凝治疗前后的变化

材料写作网    时间: 2020-10-15 04:06:26     阅读:

[摘要] 目的:研究慢性肺源性心脏病患者抗凝治疗前后抗凝血酶Ⅲ(AT-Ⅲ)和组织因子途径抑制物(TFPI)活性的变化。方法: 60例慢性肺源性心脏病患者随机分为抗凝治疗组和常规治疗组,各30例,以及健康对照组60例,分别于治疗前后采集血样检测AT-Ⅲ、TFPI活性指标。结果:慢性肺源性心脏病患者的AT-Ⅲ活性明显低于健康对照组,而TFPI活性明显高于健康对照组,两组比较,有显著性差异(P<0.05);经低分子肝素钙抗凝治疗后,AT-Ⅲ活性明显升高,常规治疗组AT-Ⅲ活性变化不大,两组比较,有显著性差异(P<0.05),而TFPI活性在两组治疗前后变化均不大,无显著性差异。结论:AT-Ⅲ及TFPI活性测定是早期预测慢性肺源性心脏病血栓前期抗凝系统变化的客观指标,对凝血机制的病理生理学研究,以及指导临床合理选用抗凝药物有重要意义。

[关键词] 慢性肺源性心脏病;抗凝血酶Ⅲ;组织因子途径抑制物;抗凝治疗

[中图分类号] R541.5[文献标识码]A [文章编号]1673-7210(2009)07(b)-011-02

Changes of anticoagulatory substances in chronic cor pulmonale patients before and after anticoagulatory treatment

YOU Shilun, WANG Huihua, WANG Huiping, LUO Qizhi

(Department of Respiratory Medicine, Buji People"s Hospital of Shenzhen City, Shenzhen 518112, China)

[Abstract] Objective: To study the changes of antithrombase Ⅲ (AT-Ⅲ) and tissue factor pathway inhibitor (TFPI) activities in chronic cor pulmonale patients before and after anticoagulatory treatment. Methods: 60 cases of chronic cor pulmonale patients were divided into two groups, anticoagulatory treatment group and conventional treatment group, with 30 cases in each group, and 60 cases of people were selected as healthy control group. The blood samples of three groups were collected before and after treatment to determine the activities of AT-Ⅲ and TFPI. Results: The AT-Ⅲ activity of chronic cor pulmonale patients was significantly lower than healthy control group, while the TFPI activity was significantly higher than healthy control group ...

== 试读已结束,如需继续阅读敬请充值会员 ==
本站文章均为原创投稿,仅供下载参考,付费用户可查看完整且有格式内容!
(费用标准:38元/2月,98元/2年,微信支付秒开通!)
升级为会员即可查阅全文 。如需要查阅全文,请 免费注册登录会员
《慢性肺源性心脏病抗凝物质抗凝治疗前后的变化.doc》
将本文的Word文档下载到电脑,方便收藏和打印
推荐度:

文档为doc格式

相关热搜

《慢性肺源性心脏病抗凝物质抗凝治疗前后的变化.doc》

VIP请直接点击按钮下载本文的Word文档下载到电脑,请使用最新版的WORD和WPS软件打开,如发现文档不全可以联系客服申请处理。

文档下载
VIP免费下载文档

浏览记录